Globus Medical Inc GMED:NYSE

RT Quote | Last NASDAQ LS, VOL From CTA | USD
Last | 05/16/24 EDT
63.95quote price arrow down-0.58 (-0.90%)
Volume
853,680
52 week range
43.38 - 65.74
Loading...
  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close63.95
  • 52 Week High65.74
  • 52 Week High Date05/08/24
  • 52 Week Low43.38
  • 52 Week Low Date11/09/23

Key Stats

  • Market Cap8.637B
  • Shares Out135.06M
  • 10 Day Average Volume0.00M
  • Dividend-
  • Dividend Yield-
  • Beta1.15
  • YTD % Change20

KEY STATS

  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close63.95
  • 52 Week High65.74
  • 52 Week High Date05/08/24
  • 52 Week Low43.38
  • 52 Week Low Date11/09/23
  • Market Cap8.637B
  • Shares Out135.06M
  • 10 Day Average Volume0.00M
  • Dividend-
  • Dividend Yield-
  • Beta1.15
  • YTD % Change20

RATIOS/PROFITABILITY

  • EPS (TTM)0.63
  • P/E (TTM)101.19
  • Fwd P/E (NTM)23.99
  • EBITDA (TTM)356.537M
  • ROE (TTM)2.28%
  • Revenue (TTM)1.898B
  • Gross Margin (TTM)62.14%
  • Net Margin (TTM)3.51%
  • Debt To Equity (MRQ)10.83%

EVENTS

  • Earnings Date08/01/2024(est)
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Globus Medical Inc

 

Profile

MORE
Globus Medical, Inc. is a medical device company that develops and commercializes healthcare solutions with a focus on improving the quality of life of patients with musculoskeletal disorders. The Company offers a portfolio of differentiated technologies that are used to treat a variety of musculoskeletal conditions. Musculoskeletal Solutions consist primarily of implantable devices, biologics, accessories, and surgical instruments used in a range of spinal, orthopedic and...
David Paul
Executive Chairman of the Board
Daniel Scavilla
President, Chief Executive Officer, Director
Keith Pfeil
Chief Financial Officer, Chief Operating Officer
Address
2560 General Armistead Ave
Audubon, PA
19403-5214
United States

Top Peers

SYMBOLLASTCHG%CHG
MASI
Masimo Corp
120.61+4.46+3.84%
PODD
Insulet Corp
185.38+4.82+2.67%
BIO
Bio Rad Laboratories Inc
295.73-5.24-1.74%
PEN
Penumbra Inc
201.53-3.17-1.55%
LNTH
Lantheus Holdings Inc
81.10+1.50+1.88%